MIBG scan for neuroblastoma explained — what parents need to know
Medically reviewed by Dr. Naresh Gundu, MD (Medical Oncology) · Last reviewed June 2026
If your child's doctor has asked for an MIBG scan, you are probably facing a difficult few days of waiting and uncertainty. This page explains exactly what the scan is, why it is ordered when neuroblastoma is suspected, what happens during the procedure, and what the results actually mean — in plain language, without medical jargon.
- Highly specific imaging — MIBG targets neuroblastoma cells throughout the body in a single scan, including any spread to bones or distant sites
- Safe for children — the tracer dose is very small and a thyroid-block medication protects your child's thyroid before the scan
- Results guide the full plan — MIBG results are reviewed alongside biopsy, blood tests, and CT to stage neuroblastoma accurately before any treatment begins
- Tumor board review — at CION, every paediatric case is discussed by a team of medical, surgical, and radiation oncologists before a single treatment decision is made
on Panel
Survival Rate*
Treated
(800+ reviews)
What is an MIBG scan, and why does your child's doctor need one?
When a doctor suspects neuroblastoma — a cancer that starts in specialised nerve cells and most commonly appears as a lump in the abdomen, chest, or neck in young children — one of the first specialist tests they order is an MIBG scan. The full name is metaiodobenzylguanidine (MIBG) scintigraphy. That is a long word for a straightforward idea: neuroblastoma cells absorb a particular chemical the way a sponge absorbs water. By attaching a tiny amount of a radioactive tag to that chemical and injecting it into your child's bloodstream, doctors can make the neuroblastoma cells visible on a special camera — wherever in the body they are.
Neuroblastoma cells contain a molecular doorway called the noradrenaline transporter, which the body normally uses to handle the stress chemical noradrenaline. MIBG closely mimics noradrenaline, so neuroblastoma cells pull it in and hold it. When the radioactive-tagged MIBG concentrates in those cells, the gamma camera records a "glow" in that area. A completely clear scan produces an even, predictable pattern of uptake in normal tissues (heart, liver, salivary glands). Unexpected bright spots elsewhere indicate where neuroblastoma cells are active.
Why is this scan particularly useful for neuroblastoma? Most other scans — CT, ultrasound, MRI — show the size and shape of a tumour but cannot easily distinguish living tumour cells from scar tissue or a benign lump. MIBG shows function: it reveals which cells are actively behaving like neuroblastoma cells, and it does this throughout the whole body in a single scan. This is important because neuroblastoma can spread widely — particularly to bones and bone marrow — and the MIBG scan is one of the most sensitive ways to detect that spread before treatment begins.
MIBG scanning is also used during and after treatment to check how the cancer is responding. A reducing number of bright spots on repeat scans is a good sign that treatment is working. For some children, a more concentrated dose of MIBG can itself become a therapy — a targeted radiation treatment that seeks out and destroys remaining neuroblastoma cells. Whether your child's MIBG scan is for diagnosis or monitoring, the results are always interpreted alongside a biopsy, blood markers, and other imaging before any treatment plan is finalised.
Neuroblastoma is the most common extracranial solid tumour in children under five years of age, and the vast majority of cases are diagnosed before a child's fifth birthday. Despite occurring in young children, neuroblastoma can behave very differently from case to case — some forms regress on their own, while others require intensive treatment. This wide range of behaviour is precisely why thorough staging using neuroblastoma imaging such as an MIBG scan is so important: the stage and biology of the tumour, not just its size, determine the treatment path. (Source: paediatric oncology consensus guidelines; SEER / ICMR paediatric cancer registry data.)
What happens during an MIBG scan — a step-by-step guide for parents
The scan unfolds over two to three days. Knowing what to expect at each stage helps both you and your child feel less anxious about the process.
-
Thyroid protection (2–3 days before the scan)
Before the scan, your child will be given a thyroid-blocking medication — usually potassium iodide drops or tablets. The thyroid gland naturally absorbs iodine; the block ensures that the radioactive iodine attached to the MIBG tracer does not accumulate in the thyroid. Your nuclear medicine team will give you the exact schedule and dosage based on your child's age and weight. This step is non-negotiable — do not skip doses, and let the team know if your child vomits a dose.
-
Tracer injection (Day 1)
On the injection day, a small amount of the radioactive MIBG tracer is given slowly through a drip (intravenous line) over about 15–30 minutes. The injection itself is not painful beyond the initial cannula placement, and the tracer has no colour, taste, or smell. Your child may feel a brief sensation of warmth as the drip goes in — this is normal and passes quickly. After the injection, your child can eat and drink normally and does not need to stay in hospital if the clinical team is satisfied.
-
Waiting period (24–48 hours after injection)
After the tracer is injected, your child returns home or to the ward and the tracer circulates through the body. Over the next 24 to 48 hours, MIBG accumulates in neuroblastoma cells (and in small amounts in normal tissues like the heart and liver). Encouraging your child to drink plenty of fluids during this period helps the kidneys clear any tracer that was not taken up by cells. Your child can play, eat normally, and sleep as usual during this time. The nuclear medicine team will tell you any specific precautions regarding close contact with younger siblings or pregnant family members during this window.
-
Gamma camera imaging (Day 2 or Day 3)
On the imaging day, your child lies on a padded table. A large gamma camera slowly moves around the body — scanning from head to toe in what is called a whole-body planar scan. This takes 45 minutes to 2 hours depending on the camera type and whether additional views (SPECT, which produces 3D images of specific areas) are needed. The camera does not touch your child and produces no noise beyond a quiet hum. The key requirement is that your child lies still; younger children (typically under 5–6 years) or those who find this difficult are given mild sedation beforehand. Your child can eat a light meal before imaging unless sedation is planned.
-
Results and team review
The images are reviewed by a nuclear medicine specialist or radiologist, who produces a written report. This report then goes to your child's oncologist — and at a centre like CION, to the full tumor board, which includes medical, surgical, and radiation oncologists. The board reviews the MIBG images alongside all other test results before presenting a treatment plan to you. This usually happens within a few days of the imaging. You deserve a full, unhurried explanation of what the results mean; do not hesitate to ask for a second appointment if you need more time to process the information.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Your child deserves a clear explanation — and a team, not just a single opinion
At CION, every paediatric case is reviewed by a tumor board before any decision is made. We walk this journey with you — one honest step at a time.
What the MIBG scan tells doctors — and what happens next
An MIBG scan is not a pass-or-fail test. It is a detailed map that feeds into a larger picture. Here is what oncologists actually look at when they review neuroblastoma imaging results.
Where the primary tumour is
The brightest area of MIBG uptake usually corresponds to the primary tumour — most often in the adrenal gland (sitting on top of the kidney) or along the chain of sympathetic nerve tissue that runs beside the spine. Knowing the exact location helps the surgical team plan whether and how the tumour can be removed.
Whether the cancer has spread to bones
Neuroblastoma frequently spreads to the skeleton — particularly the skull, spine, ribs, and long bones of the limbs. MIBG lights up these bone deposits (called metastases) across the whole body in one scan session, which is something a standard CT cannot do without multiple separate scans. Bone involvement affects staging and, with it, the intensity of treatment.
The disease stage (how far it has spread)
International neuroblastoma risk-group guidelines (INRG) use staging that depends partly on whether the disease has spread to distant sites. The MIBG scan, combined with a bone marrow biopsy, provides the evidence for whether spread is present. Stage is one of the most important factors in deciding whether a child needs observation, surgery alone, or intensive chemotherapy followed by high-dose treatment.
How well treatment is working
Repeat MIBG scans are done during and after chemotherapy to measure response. If the bright spots are shrinking or disappearing, the cancer is responding. If new spots appear or old ones grow, the team will review whether a different treatment approach is needed. This ongoing monitoring is one of the key ways oncologists personalise treatment rather than following a fixed schedule regardless of individual response.
Whether MIBG therapy is an option
For children with relapsed or treatment-resistant neuroblastoma, a higher dose of radioactive MIBG can itself become a therapy — directly delivering radiation to wherever the tracer accumulates. But this treatment is only possible if the diagnostic MIBG scan confirms the tumour cells absorb MIBG well (MIBG-avid disease). A diagnostic scan that shows good uptake opens the door to this targeted option if it becomes needed later in the treatment journey.
A baseline for long-term follow-up
Even after treatment is complete, children who have had neuroblastoma are monitored with regular scans for several years. The initial MIBG scan creates a baseline that every future scan is compared against. Doctors look for any change from that baseline — a new area of uptake can be an early sign of relapse that is detected while still very small and potentially still treatable. Regular follow-up is not a sign something is wrong; it is part of the care plan that keeps your child safe long after treatment ends.
For more information about paediatric cancer care at CION, or to read about neuroblastoma treatment options in Hyderabad, visit our paediatric hub page.
A 45-minute consultation, no rushed questions, no billing surprises
We walk every family through what an MIBG scan means for their child — not with jargon, but with honesty and time. Every decision is for healing, not billing.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.MIBG scan and neuroblastoma — questions parents ask most
Explore All Pediatric Cancer Topics
Browse our complete library of parent-facing guides, grouped by topic — from warning signs and cancer types to diagnosis, treatment, side-effect care, survivorship and family support.